Webcast: Optimal Use of Autologous Transplantation and Stem Cell Mobilization in Patients with Multiple Myeloma and Non-Hodgkin's Lymphoma
The goal of this educational program is to improve the treatment of patients with multiple myeloma (MM) and non-hodgkin lymphoma (NHL) through the dissemination of information about stem cell transplantation and mobilization for autologous hematopoietic cell transplantation. The data for stem cell transplantation in MM is rapidly changing. The techniques of mobilization are still evolving. There is considerable debate regarding the timing and number of transplants for MM and the indications for transplant in NHL. The optimal use of transplant in the disease course and appropriate mobilization could drastically change the treatment of MM and NHL. This program serves as a medium to give physicians a chance to recognize these changes. Here is the link to the Activity:  https://www.bloodline.net/optimal-use-of-autologous-transplantation-and-stem-cell-mobilization-in-patients/
Category
  • Lymphoma, Non-Hodgkins
  • Multiple Myeloma
  • Stem Cell Transplantation
Format
  • Online
Credits
  • AMA PRA Category 1 Credit(s)™
  • Hours of Participation
Monograph: Optimal Use of Autologous Transplantation & Stem Cell Mobilization in Patients with Multiple Myeloma and Non-Hodgkin's Lymphoma
The goal of this educational program is to improve the treatment of patients with multiple myeloma (MM) and non-hodgkin lymphoma (NHL) through the dissemination of information about stem cell transplantation and mobilization for autologous hematopoietic cell transplantation. The data for stem cell transplantation in MM is rapidly changing. The techniques of mobilization are still evolving. There is considerable debate regarding the timing and number of transplants for MM and the indications for transplant in NHL. The optimal use of transplant in the disease course and appropriate mobilization could drastically change the treatment of MM and NHL. This program serves as a medium to give physicians a chance to recognize these changes. Here is the link to the Activity:  https://www.bloodline.net/optimal-use-of-autologous-transplantation-and-stem-cell-mobilization-in-patients/
Category
  • Lymphoma, Non-Hodgkins
  • Multiple Myeloma
  • Stem Cell Transplantation
Format
  • Online
Credits
  • AMA PRA Category 1 Credit(s)™
  • Hours of Participation
Scholars in Patient Safety and Quality Improvement January 2019
Category
Format
Credits
  • AMA PRA Category 1 Credit(s)™
  • Hours of Participation
Event date January 28, 2019
2019 MCW Pancreatic Cancer Clinical Symposium
Over 45,000 people in the US annually are affected by Pancreatic Cancer.
Category
Format
Credits
  • AMA PRA Category 1 Credit(s)™
  • Hours of Participation
Event date January 25, 2019
AASLD 2018 Meeting Review
The field of Hepatology is rapidly changing.  Most gastroenterologists in the community are using outdated therapeutic regimens.  This conference will allow us to present the most up-to-date information to the attendees.
Category
Format
Credits
  • AMA PRA Category 1 Credit(s)™
  • Hours of Participation
Event date February 2, 2019
MCW - Responsible Opioid Prescribing Guidelines Continuing Education Course (MED-1009) 2019
From The Wisconsin Medical Examining Board:
Category
Format
  • Online
Credits
  • AMA PRA Category 1 Credit(s)™
  • Hours of Participation
  • NP Contact Hours
  • NP Pharmacology
  • PA
Responsible Opioid Prescribing Guidelines Continuing Education Course (MED-1009) 2019
If you are MCW Faculty, MCP, CSG, CMG, CP and Zablocki VA please (CLICK HERE)
Category
  • Opioids
Format
  • Online
Credits
  • AMA PRA Category 1 Credit(s)™
  • NP Contact Hours
  • NP Pharmacology
  • PA
Webcast - Expanding Role of Immunotherapy in Bladder Cancer Treatment (IBCU2)
Welcome to the online CME program “The Expanding Role of Immunotherapy in Bladder Cancer Treatment”. To complete the activity, you will first need to do the pre-test and then watch and learn from two video lectures. Once this course is completed, you will be redirected to the Medical College of Wisconsin’s website to claim your CME for this activity. Program Goal The goal of this educational program is to equip urologists, medical oncologists, radiation oncologists, and other healthcare providers nationwide who are involved in the treatment of patients with bladder cancer with the upto-date clinical knowledge and tools they need to best diagnose and treat their patients. With growing advancements in immunotherapy treatment of bladder cancer, patients may experience better treatment outcomes. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Medical College of Wisconsin and Carden Jennings Publishing. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.  The Medical College of Wisconsin designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  Link to this activity:  https://grandroundsinurology.com/courses/the-expanding-role-of-immunotherapy-in-bladder-cancer-treatment/
Category
Format
  • Online
Credits
  • AMA PRA Category 1 Credit(s)™
  • Hours of Participation
19114 Breast Cancer 1/24/2019
Category
Format
Credits
  • AMA PRA Category 1 Credit(s)™
  • Hours of Participation
Event date January 24, 2019
19114 Breast Reconstruction (Autologous)1/31/2019
Category
Format
Credits
  • AMA PRA Category 1 Credit(s)™
  • Hours of Participation
Event date January 31, 2019

Pages